Advanced company searchLink opens in new window

CELLERON THERAPEUTICS LIMITED

Company number 05162047

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Sep 2023 AA Total exemption full accounts made up to 30 June 2023
27 Jun 2023 CS01 Confirmation statement made on 24 June 2023 with updates
14 Mar 2023 MA Memorandum and Articles of Association
14 Mar 2023 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
10 Mar 2023 TM01 Termination of appointment of David James Kerr as a director on 21 February 2023
09 Mar 2023 TM01 Termination of appointment of James Julian Noble as a director on 21 February 2023
09 Mar 2023 TM01 Termination of appointment of Richard Kirby Taylor as a director on 21 February 2023
30 Jan 2023 PSC05 Change of details for Celleron Therapeutics Holdings Limited as a person with significant control on 26 January 2023
24 Jan 2023 TM02 Termination of appointment of Douglas Fraser Mcdonald as a secretary on 22 December 2022
17 Jan 2023 SH08 Change of share class name or designation
16 Jan 2023 PSC02 Notification of Celleron Therapeutics Holdings Limited as a person with significant control on 22 December 2022
16 Jan 2023 PSC07 Cessation of Nicholas Barrie La Thangue as a person with significant control on 22 December 2022
16 Jan 2023 TM01 Termination of appointment of Sangwoo Lee as a director on 22 December 2022
28 Sep 2022 AA Total exemption full accounts made up to 30 June 2022
15 Sep 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
18 Jul 2022 CS01 Confirmation statement made on 24 June 2022 with updates
01 Jul 2022 PSC04 Change of details for Prof Nicholas Barrie La Thangue as a person with significant control on 24 June 2022
30 Jun 2022 CH01 Director's details changed for Mr James Noble on 24 June 2022
30 Jun 2022 CH01 Director's details changed for Prof Nicholas Barrie La Thangue on 24 June 2022
30 Jun 2022 CH01 Director's details changed for Prof Nicholas Barrie La Thangue on 30 June 2022
30 Jun 2022 PSC04 Change of details for Prof Nicholas Barrie La Thangue as a person with significant control on 24 June 2022
30 Jun 2022 CH01 Director's details changed for Prof Nicholas Barrie La Thangue on 24 June 2022
11 Apr 2022 PSC04 Change of details for Prof Nicholas Barrie La Thangue as a person with significant control on 7 April 2016
25 Mar 2022 TM01 Termination of appointment of Katherine Innes-Ker as a director on 24 March 2022
04 Mar 2022 CH01 Director's details changed for Prof Nicholas Barrie La Thangue on 4 March 2022